First Heartland Consultants’s ARK Genomic Revolution ETF ARKG Stock Holding History

First Heartland Consultants’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,844	Closed	-$222K	–	349
2022 Q1	$222K	Sell	4,844 -486	-9%	-$23.2K	0.03%	317
2021 Q4	$326	Sell	5,330 -398	-7%	-$27.5K	0.01%	260
2021 Q3	$428K	Sell	5,728 -200	-3%	-$16.8K	0.07%	225
2021 Q2	$548K	Buy	5,928 +190	+3%	+$16.2K	0.08%	201
2021 Q1	$509K	Buy	+5,738	New	+$569K	0.08%	199

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

First Heartland Consultants's ARKG Position: Q2 2022 in Review

First Heartland Consultants sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,844 shares — an estimated $222K sold.

First Heartland Consultants first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $548K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

First Heartland Consultants reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
First Heartland Consultants sold 4,844 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $222K.
First Heartland Consultants first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
First Heartland Consultants's ARK Genomic Revolution ETF position peaked at $548K in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on First Heartland Consultants's 13F filing for Q2 2022, filed 12 Jul 2022.